FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082589463> ?p ?o ?g. }

• W3082589463 endingPage "6417" @default.
• W3082589463 startingPage "6417" @default.
• W3082589463 abstract "Atherosclerosis is a chronic inflammatory disease, whose progression and stability are modulated, among other factors, by an innate and adaptive immune response. Prodiginines are bacterial secondary metabolites with antiproliferative and immunomodulatory activities; however, their effect on the progression or vulnerability of atheromatous plaque has not been evaluated. This study assessed the therapeutic potential of prodigiosin and undecylprodigiosin on inflammatory marker expression and atherosclerosis. An in vitro and in vivo study was carried out. Migration, low-density lipoprotein (LDL) uptake and angiogenesis assays were performed on cell types involved in the pathophysiology of atherosclerosis. In addition, male LDL receptor null (Ldlr-/-) C57BL/6J mice were treated with prodigiosin or undecylprodigiosin for 28 days. Morphometric analysis of atherosclerotic plaques, gene expression of atherogenic factors in the aortic sinus and serum cytokine quantification were performed. The treatments applied had slight effects on the in vitro tests performed, highlighting the inhibitory effect on the migration of SMCs (smooth muscle cells). On the other hand, although no significant difference in atherosclerotic plaque progression was observed, gene expression of IL-4 and chemokine (C-C motif) ligand 2 (Ccl2) was downregulated. In addition, 50 µg/Kg/day of both treatments was sufficient to inhibit circulating tumor necrosis factor alpha (TNF-α), interleukin-2 (IL-2) and interferon-gamma (IFN-γ) in serum. These results suggested that prodigiosin and undecylprodigiosin modulated inflammatory markers and could have an impact in reducing atherosclerotic plaque vulnerability." @default.
• W3082589463 created "2020-09-08" @default.
• W3082589463 creator A5000568007 @default.
• W3082589463 creator A5007141435 @default.
• W3082589463 creator A5068108297 @default.
• W3082589463 creator A5075621411 @default.
• W3082589463 creator A5075846260 @default.
• W3082589463 creator A5080428881 @default.
• W3082589463 date "2020-09-03" @default.
• W3082589463 modified "2023-10-11" @default.
• W3082589463 title "Prodigiosin Modulates the Immune Response and Could Promote a Stable Atherosclerotic Lession in C57bl/6 Ldlr-/- Mice" @default.
• W3082589463 cites W1615956555 @default.
• W3082589463 cites W1695676538 @default.
• W3082589463 cites W1711911362 @default.
• W3082589463 cites W1749175061 @default.
• W3082589463 cites W1970851689 @default.
• W3082589463 cites W1975750642 @default.
• W3082589463 cites W1981677263 @default.
• W3082589463 cites W1985236996 @default.
• W3082589463 cites W1992241408 @default.
• W3082589463 cites W1994207431 @default.
• W3082589463 cites W1999131804 @default.
• W3082589463 cites W2005743585 @default.
• W3082589463 cites W2010802459 @default.
• W3082589463 cites W2014087704 @default.
• W3082589463 cites W2022713146 @default.
• W3082589463 cites W2025300710 @default.
• W3082589463 cites W2026666800 @default.
• W3082589463 cites W2040533844 @default.
• W3082589463 cites W2045527166 @default.
• W3082589463 cites W2046551442 @default.
• W3082589463 cites W2046864860 @default.
• W3082589463 cites W2049746695 @default.
• W3082589463 cites W2056245899 @default.
• W3082589463 cites W2059695211 @default.
• W3082589463 cites W2072389344 @default.
• W3082589463 cites W2086168074 @default.
• W3082589463 cites W2091173515 @default.
• W3082589463 cites W2091557419 @default.
• W3082589463 cites W2092423235 @default.
• W3082589463 cites W2094708689 @default.
• W3082589463 cites W2101179492 @default.
• W3082589463 cites W2108244474 @default.
• W3082589463 cites W2109121619 @default.
• W3082589463 cites W2110284750 @default.
• W3082589463 cites W2117419186 @default.
• W3082589463 cites W2118532131 @default.
• W3082589463 cites W2131873950 @default.
• W3082589463 cites W2135500248 @default.
• W3082589463 cites W2136208700 @default.
• W3082589463 cites W2140786019 @default.
• W3082589463 cites W2161535127 @default.
• W3082589463 cites W2163192757 @default.
• W3082589463 cites W2163504963 @default.
• W3082589463 cites W2165638392 @default.
• W3082589463 cites W2168660808 @default.
• W3082589463 cites W2169495853 @default.
• W3082589463 cites W2274924551 @default.
• W3082589463 cites W2341939628 @default.
• W3082589463 cites W2401325010 @default.
• W3082589463 cites W2498215202 @default.
• W3082589463 cites W2509137894 @default.
• W3082589463 cites W2792895473 @default.
• W3082589463 cites W2803326208 @default.
• W3082589463 cites W2909833291 @default.
• W3082589463 cites W2929112667 @default.
• W3082589463 cites W2938688210 @default.
• W3082589463 cites W99964119 @default.
• W3082589463 doi "https://doi.org/10.3390/ijms21176417" @default.
• W3082589463 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7504388" @default.
• W3082589463 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32899258" @default.
• W3082589463 hasPublicationYear "2020" @default.
• W3082589463 type Work @default.
• W3082589463 sameAs 3082589463 @default.
• W3082589463 citedByCount "6" @default.
• W3082589463 countsByYear W30825894632020 @default.
• W3082589463 countsByYear W30825894632022 @default.
• W3082589463 countsByYear W30825894632023 @default.
• W3082589463 crossrefType "journal-article" @default.
• W3082589463 hasAuthorship W3082589463A5000568007 @default.
• W3082589463 hasAuthorship W3082589463A5007141435 @default.
• W3082589463 hasAuthorship W3082589463A5068108297 @default.
• W3082589463 hasAuthorship W3082589463A5075621411 @default.
• W3082589463 hasAuthorship W3082589463A5075846260 @default.
• W3082589463 hasAuthorship W3082589463A5080428881 @default.
• W3082589463 hasBestOaLocation W30825894631 @default.
• W3082589463 hasConcept C101666144 @default.
• W3082589463 hasConcept C104317684 @default.
• W3082589463 hasConcept C11988809 @default.
• W3082589463 hasConcept C126322002 @default.
• W3082589463 hasConcept C13373296 @default.
• W3082589463 hasConcept C17991360 @default.
• W3082589463 hasConcept C203014093 @default.
• W3082589463 hasConcept C2776309202 @default.
• W3082589463 hasConcept C2776914184 @default.
• W3082589463 hasConcept C2778163477 @default.
• W3082589463 hasConcept C2779337610 @default.
• W3082589463 hasConcept C2780072125 @default.

• next